n,n-dimethylarginine has been researched along with Cerebral Hemorrhage in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, D; Böger, R; Czorlich, P; Haddad, M; Hannemann, J; Lamszus, K; Mader, MM; Mohme, M; Schwedhelm, E; Westphal, M | 1 |
| Chen, S; Deb, M; Li, N; Weissenborn, K; Worthmann, H | 1 |
| Brattström, L; Brudin, L; Carlsson, M; Nilsson, I; Palmqvist, P; Teerlink, T; Wanby, P | 1 |
1 review(s) available for n,n-dimethylarginine and Cerebral Hemorrhage
| Article | Year |
|---|---|
Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage.
Topics: Animals; Arginine; Cerebral Hemorrhage; Humans; Nitric Oxide; Nitric Oxide Synthase | 2011 |
2 other study(ies) available for n,n-dimethylarginine and Cerebral Hemorrhage
| Article | Year |
|---|---|
Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage.
Topics: Aged; Arginine; Case-Control Studies; Cerebral Hemorrhage; Chromatography, High Pressure Liquid; Citrulline; Female; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Risk Factors; Tandem Mass Spectrometry; Up-Regulation | 2021 |
Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Topics: Acute Disease; Aged; Arginine; Biomarkers; Cerebral Hemorrhage; Cerebral Infarction; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Ischemic Attack, Transient; Male; Multivariate Analysis; Nitric Oxide Synthase; Odds Ratio; Risk Factors; Stroke | 2006 |